Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedline versus BIS monitoring during ciprofol general anesthesia
ChiCTR2200065872Phase 4Not yet recruiting
- Sponsor
- The Fourth Hospital of Harbin Medical University
- Start
- Nov 2022
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in Breast abnormality, breast cancer and benign breast neoplasm (2 arms), sponsored by The Fourth Hospital of Harbin Medical University. Primary endpoint: Intraoperative sedation depth. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
ciprofol
03
Conditions
Breast abnormalitybreast cancerbenign breast neoplasm
Beyond the preview
Go deeper on ChiCTR2200065872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065872.